Andere Sprachen Bone Biologics Corporation

Aktien

A3E3TN

US0980705018

BBLG

Markt geschlossen - Nasdaq Andere Börsenplätze 22:30:01 06.05.2024			% 5 Tage	% 1. Jan.
1.83 ^USD	-1.08%		+16.93%	-59.51%

01.03.	Bone Biologics Corporation meldet Fortschritte beim klinischen Programm NB1	CI
21.02.	Bone Biologics Corporation berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Certain Common Stock of Bone Biologics Corporation are subject to a Lock-Up Agreement Ending on 4-MAY-2024.	04.05.
Certain Warrants of Bone Biologics Corporation are subject to a Lock-Up Agreement Ending on 4-MAY-2024.	04.05.
Certain Stock Options of Bone Biologics Corporation are subject to a Lock-Up Agreement Ending on 4-MAY-2024.	04.05.
Bone Biologics Announces Closing of $2.0 Million Public Offering	06.03.
Bone Biologics Announces Pricing of $2.0 Million Public Offering	04.03.
Bone Biologics Corporation Reports Progress with NB1 Clinical Program	01.03.
Bone Biologics Reports Progress With NB1 Clinical Program	01.03.
Bone Biologics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	21.02.
Bone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of Directors	11.01.
Bone Biologics Corporation Announces Board Changes	11.01.
Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements	10.01.
Bone Biologics Corporation Announces the Resignation of Erick Lucera as Director	02.01.
Bone Biologics' 1-for-8 Reverse Stock Split Takes Effect Wednesday	18.12.
Bone Biologics Announces 1-for-8 Reverse Stock Split	18.12.
Bone Biologics Closes Common Stock Offering; Shares Fall After Hours	20.11.
Bone Biologics Announces Closing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	20.11.
Bone Biologics Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	16.11.
Bone Biologics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14.11.
Nano-Cap Medical Technology Watchlist (ORHB, BBLG, ICU, RMTI)	02.10.23
Bone Biologics Provides Scientific Update on NB1 Bone Graft Device	26.09.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Bone Biologics Corporation

Aktien

A3E3TN

US0980705018

BBLG

Andere Sprachen

Filter